Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Landscape of driver mutations and their clinical effects on Down syndrome–related myeloid neoplasms

Tomohiko Sato, Kenichi Yoshida, Tsutomu Toki, Rika Kanezaki, Kiminori Terui, Ryunosuke Saiki, Masami Ojima, Yotaro Ochi, Seiya Mizuno, Masaharu Yoshihara, Tamayo Uechi, Naoya Kenmochi, Shiro Tanaka, Jun Matsubayashi, Kenta Kisai, Ko Kudo, Kentaro Yuzawa, Yuka Takahashi, Tatsuhiko Tanaka, Yohei Yamamoto, Akie Kobayashi, Takuya Kamio, Shinya Sasaki, Yuichi Shiraishi, Kenichi Chiba, Hiroko Tanaka, Hideki Muramatsu, Asahito Hama, Daisuke Hasegawa, Atsushi Sato, Katsuyoshi Koh, Shuhei Karakawa, Masao Kobayashi, Junichi Hara, Yuichi Taneyama, Chihaya Imai, Daiichiro Hasegawa, Naoto Fujita, Masahiro Yoshitomi, Shotaro Iwamoto, Genki Yamato, Satoshi Saida, Nobutaka Kiyokawa, Takao Deguchi, Masafumi Ito, Hidemasa Matsuo, Souichi Adachi, Yasuhide Hayashi, Takashi Taga, Akiko M. Saito, Keizo Horibe, Kenichiro Watanabe, Daisuke Tomizawa, Satoru Miyano, Satoru Takahashi, Seishi Ogawa, Etsuro Ito

Blood (2024) 143 (25): 2627–2643.

https://doi.org/10.1182/blood.2023022247

Published: 2024

Includes: Supplemental data

Journal Articles

Label-Free Cell Detection of Acute Leukemia Using High-Content Morphological Profiling in Flow

Yoko Kawamura, Kayoko Nakanishi, Yuri Murata, Kazuki Teranishi, Ryusuke Miyazaki, Keisuke Toda, Toru Imai, Yasuhiro Kajiwara, Keiji Nakagawa, Hidemasa Matsuo, Souichi Adachi, Sadao Ota, Hidefumi Hiramatsu

Blood (2023) 142 (Supplement 1): 906.

https://doi.org/10.1182/blood-2023-188914

Published: 2023

Journal Articles

Suppression of Super-Enhancer-Driven TAL1 Expression By KLF4 in T-Cell Acute Lymphoblastic Leukemia

Mina Noura, Takahiko Yasuda, Shinobu Tsuzuki, Hidemasa Matsuo, Hitoshi Kiyoi, Fumihiko Hayakawa

Blood (2023) 142 (Supplement 1): 1405.

https://doi.org/10.1182/blood-2023-173640

Published: 2023

Journal Articles

Clonal Evolution Pattern and Prognostic Significance of Clonal Architecture in KMT2A -Rearranged Acute Myeloid Leukemia

Blood (2021) 138 (Supplement 1): 2358.

https://doi.org/10.1182/blood-2021-146699

Published: 2021

Journal Articles

KRAS mutations Frequently Coexist with High-Risk MLL Fusions and Are Independent Adverse Prognostic Factors in MLL -Rearranged Acute Myeloid Leukemia

Blood (2020) 136 (Supplement 1): 28–29.

https://doi.org/10.1182/blood-2020-134648

Published: 2020

Journal Articles

RUNX-NFAT Axis As a Novel Therapeutic Target for AML and T Cell Immunity

Tatsuya Masuda, Master Degree, Hirohito Kubota, MD, Naoya Sakuramoto, Master Degree, Asuka Hada, Master Degree, Ayaka Horiuchi, Master Degree, Asami Sasaki, Master Degree, Kanako Takeda, Master Degree, Mizuho Takeda, Master Degree, Hidemasa Matsuo, Hiroshi Sugiyama, PhD, Souichi Adachi, MD PhD, Yasuhiko Kamikubo

Blood (2020) 136 (Supplement 1): 25–26.

https://doi.org/10.1182/blood-2020-143458

Published: 2020

Journal Articles

Autophagy Inhibition Enhances CDK4/6 Inhibitor-Induced Apoptosis in t(8;21) Acute Myeloid Leukemia Cells

Kana Nakatani, Hidemasa Matsuo, Yutarou Harata, Moe Higashitani, Asami Koyama, Mina Noura, Yoko Nishinaka-Arai, PhD, Yasuhiko Kamikubo, Souichi Adachi, MD PhD

Blood (2020) 136 (Supplement 1): 50.

https://doi.org/10.1182/blood-2020-133881

Published: 2020

Journal Articles

Recurrent Gene Mutations in Pediatric Patients with AML By Targeted Sequencing ―the Jccg Study, JPLSG AML-05―

Blood (2019) 134 (Supplement_1): 2697.

https://doi.org/10.1182/blood-2019-126545

Published: 2019

Journal Articles

Clinical Features of Pediatric Acute Myeloid Leukemia with TP53 and CDKN2A / 2B copy Number Alterations

Blood (2019) 134 (Supplement_1): 2727.

https://doi.org/10.1182/blood-2019-126263

Published: 2019

Journal Articles

The Detection of Minor Clones with Somatic KIT D816V Mutations Using Droplet Digital PCR in Pediatric De Novo AML: AML-05 Trial from the Japanese Pediatric Leukemia/Lymphoma Study Group

Blood (2019) 134 (Supplement_1): 1419.

https://doi.org/10.1182/blood-2019-127656

Published: 2019

Journal Articles

Coexistence and Prognostic Significance of EVI1 Expression and Driver Mutations in KMT2A -Rearranged Acute Myeloid Leukemia

Hidemasa Matsuo, PhD, Kenichi Yoshida, MD PhD, Kana Nakatani, Yasuhiko Kamikubo, MD, PhD, Daisuke Tomizawa, MD PhD, Takashi Taga, MD PhD, Nobutaka Kiyokawa, MD PhD, Seishi Ogawa, MD PhD, Manja Meggendorfer, PhD, Claudia Haferlach, MD, Souichi Adachi, MD PhD

Blood (2019) 134 (Supplement_1): 1409.

https://doi.org/10.1182/blood-2019-124652

Published: 2019

Journal Articles

Comprehensive Analysis of 343 Genes Using Targeted Sequencing Panel By Next-Generation Sequencer in 77 Pediatric AML Patients with Normal and Complex Karyotypes: Jccg Study, JPLSG AML-05

Taeko Kaburagi, Genki Yamato, MD PhD, Norio Shiba, MD, Kenichi Yoshida, MD PhD, Yusuke Hara, MD PhD, Yuichi Shiraishi, PhD, Kentaro Ohki, MD PhD, Manabu Sotomatsu, MD PhD, Hirokazu Arakawa, MD PhD, Hidemasa Matsuo, PhD, Akira Shimada, MDPhD, Nobutaka Kiyokawa, MD PhD, Daisuke Tomizawa, MD PhD, Takashi Taga, MD PhD, Keizo Horibe, MD PhD, Satoru Miyano, PhD, Seishi Ogawa, MD PhD, Souichi Adachi, MD PhD, Yasuhide Hayashi, MD PhD

Blood (2018) 132 (Supplement 1): 1530.

https://doi.org/10.1182/blood-2018-99-114632

Published: 2018

Journal Articles

Recurrent Genomic Aberrations of D-Type Cyclins Are Therapeutic Targets of CDK4/6 Inhibitors in t(8;21) and MLL -Rearranged Acute Myeloid Leukemia

Blood (2018) 132 (Supplement 1): 2797.

https://doi.org/10.1182/blood-2018-99-111073

Published: 2018

Journal Articles

Cell-Autonomous Feedback Loop of RUNX1-p53-CBFB in Acute Myeloid Leukemia Cells

Mina Noura, Ken Morita, MD, PhD, Chieko Tokushige, Shintaro Maeda, Hiroki Kiyose, Toshikazu Bando, PhD, Kenichi Yoshida, MD PhD, Hidemasa Matsuo, Seishi Ogawa, MD PhD, Paul P. Liu, MD, PhD, Hiroshi Sugiyama, PhD, Yasuhiko Kamikubo, MD, PhD, Souichi Adachi, MD PhD

Blood (2017) 130 (Supplement 1): 1232.

https://doi.org/10.1182/blood.V130.Suppl_1.1232.1232

Published: 2017

Journal Articles

Prognostic Significance of CXCR4 Overexpression in Pediatric Acute Myeloid Leukemia with Low-Risk: A Report from the Japanese Pediatric Leukemia/Lymphoma Study Group

Hidemasa Matsuo, MS, Naomi Nakamura, MS, Daisuke Tomizawa, MD PhD, Akiko M. Saito, Nobutaka Kiyokawa, MDPhD, Keizo Horibe, MD PhD, Yoko Nishinaka-Arai, PhD, Mayu Tokumasu, MD, Hiroshi Itoh, MS, Yasuhiko Kamikubo, MD PhD, Hideki Nakayama, MD PhD, Akitoshi Kinoshita, MD PhD, Takashi Taga, MD PhD, Akio Tawa, MD PhD, Tomohiko Taki, MD PhD, Shiro Tanaka, PhD, Souichi Adachi, MD PhD

Blood (2015) 126 (23): 3814.

https://doi.org/10.1182/blood.V126.23.3814.3814

Published: 2015

Journal Articles

Double CEBPA Mutations Are Not Associated With Favorable Clinical Outcome In Pediatric AML: A Report From The Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)

Hidemasa Matsuo, MT (ASCPi), Mio Kajihara, Daisuke Tomizawa, MD, PhD, Tomoyuki Watanabe, PhD, Akiko Moriya Saito, MD, PhD, Junichiro Fujimoto, MD, PhD, Keizo Horibe, MD, PhD, Mayu Tokumasu, MD, Hiroshi Itoh, Hideki Nakayama, MD, PhD, Akitoshi Kinoshita, MD, PhD, Takashi Taga, MD, PhD, Akio Tawa, MD, PhD, Tomohiko Taki, MD, PhD, Souichi Adachi, MD, PhD

Blood (2013) 122 (21): 4942.

https://doi.org/10.1182/blood.V122.21.4942.4942

Published: 2013

NARROW

Landscape of driver mutations and their clinical effects on Down syndrome–related myeloid neoplasms

Label-Free Cell Detection of Acute Leukemia Using High-Content Morphological Profiling in Flow

Suppression of Super-Enhancer-Driven TAL1 Expression By KLF4 in T-Cell Acute Lymphoblastic Leukemia

Clonal Evolution Pattern and Prognostic Significance of Clonal Architecture in KMT2A -Rearranged Acute Myeloid Leukemia

KRAS mutations Frequently Coexist with High-Risk MLL Fusions and Are Independent Adverse Prognostic Factors in MLL -Rearranged Acute Myeloid Leukemia

RUNX-NFAT Axis As a Novel Therapeutic Target for AML and T Cell Immunity

Autophagy Inhibition Enhances CDK4/6 Inhibitor-Induced Apoptosis in t(8;21) Acute Myeloid Leukemia Cells

Recurrent Gene Mutations in Pediatric Patients with AML By Targeted Sequencing ―the Jccg Study, JPLSG AML-05―

Clinical Features of Pediatric Acute Myeloid Leukemia with TP53 and CDKN2A / 2B copy Number Alterations

The Detection of Minor Clones with Somatic KIT D816V Mutations Using Droplet Digital PCR in Pediatric De Novo AML: AML-05 Trial from the Japanese Pediatric Leukemia/Lymphoma Study Group

Coexistence and Prognostic Significance of EVI1 Expression and Driver Mutations in KMT2A -Rearranged Acute Myeloid Leukemia

Comprehensive Analysis of 343 Genes Using Targeted Sequencing Panel By Next-Generation Sequencer in 77 Pediatric AML Patients with Normal and Complex Karyotypes: Jccg Study, JPLSG AML-05

Recurrent Genomic Aberrations of D-Type Cyclins Are Therapeutic Targets of CDK4/6 Inhibitors in t(8;21) and MLL -Rearranged Acute Myeloid Leukemia

Cell-Autonomous Feedback Loop of RUNX1-p53-CBFB in Acute Myeloid Leukemia Cells

Prognostic Significance of CXCR4 Overexpression in Pediatric Acute Myeloid Leukemia with Low-Risk: A Report from the Japanese Pediatric Leukemia/Lymphoma Study Group

Double CEBPA Mutations Are Not Associated With Favorable Clinical Outcome In Pediatric AML: A Report From The Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only